Delir bei Demenz

Zusammenfassung

Delir und Demenz zeigen als organisch bedingte psychische Störungen Gemeinsamkeiten in klinischer und neurobiologischer Hinsicht und treten häufig gemeinsam auf. Das Vorliegen der einen scheint das Risiko zur Entwicklung der jeweils anderen Störung zu erhöhen. Obwohl das Delir gerade bei älteren Patienten eine häufige Störung ist, wird es oft übersehen. Zur Diagnostik des Delirs reichen aber nicht selten eine genaue Anamnese inklusive Medikamentenanamnese, klinische Untersuchung und Bestimmung von laborchemischen Routineparametern aus. Die kausale Behandlung des Delirs ist möglich und nicht unbedingt kompliziert. Zur symptomatischen Behandlung stehen nicht-medikamentöse und medikamentöse Maßnahmen zur Verfügung. Die nicht-medikamentösen Maßnahmen werden zu einem großen Teil vom pflegenden Personal ausgeführt und beinhalten u. a. Orientierungshilfen und Balance zwischen Reizüberflutung und -deprivation. Gute Kenntnis der Symptomatologie ist entscheidend auch im Hinblick auf die Prävention (Delirfachschwester). Zur symptomatischen medikamentösen Behandlung erscheinen Neuroleptika günstig. Im Hinblick auf extrapyramidale Nebenwirkungen sind Typika den Atypika unterlegen. Der Einsatz von Cholinesterase-Inhibitoren kann aus der Literatur nicht belastbar gestützt werden. Zu Benzodiazepinen wird außer zur Behandlung von Entzugsdelirien eher nicht geraten. Präparate mit kurzer Halbwertszeit und fehlenden aktiven Metaboliten können jedoch kurzzeitig flankierend eingesetzt werden. Besonders wichtig erscheint die Prävention, zu der gute Kenntnisse der Risikofaktoren und ihres Managements beim behandelnden Personal von zentraler Bedeutung sind. Als Sonderfall erscheint das Auftreten eines Delirs im Rahmen von alpha-Synukleinopathien. Internationale und deutsche Richtlinien zum Management des Delirs existieren.

Abstract

Delirium and dementia as organically caused mental disorders exhibit similarities in the clinical and neurological sense and often occur together. The existence of one appears to increase the risk for the development of the other. Although delirium is a very common disorder especially among the elderly, it is often not recognized. For the diagnosis of delirium, an exact family and case history including medication, clinical examination and determination of routine laboratory values are not infrequently necessary. Causal treatment of delirium is possible and not necessarily complicated. Both non-medicative and medicative measures are available for the symptomatic treatment. The non-medicative measures are to a large extent applied by nursing staff and comprise, among others, orientation guidance and attaining a balance between perceptual overload and deprivation. A good knowledge of symptomatology is decisive, also from the prevention point of view (nurses specialized in delirium). For symptomatic medicative treatment neuroleptic agents appear to be favorable. With regard to extrapyramidal side effects atypical neuroleptics are better than the typical ones. The use of cholinesterase inhibitors is not robustly supported by the literature. The use of benzodiazepines is rather discouraged except for the treatment of withdrawal delirium. Preparations with short half-lives and absence of active metabolites can be used as accompanying measures for a short time. Prevention appears to be extremely important for which the treating personnel require a good knowledge of risk factors and their management. The occurrence of delirium among cases of alpha-synucleinopathies represents a special case. Both international and German guidelines on the management of delirium are available.

Schlüsselwörter

Delirium - Dementia - Treatment

Key words

delirium - dementia - treatment

• Literatur

• 1 Wallesch CW, Foerstl H. Demenzen. Stuttgart: Thieme; 2012
• 2 Payk TR. Psychopathologie. Vom Symptom zur Diagnose. Heidelberg: Springer; 2010
• 3 Cole MG. Delirium in elderly patients. Am J of Geriatr Psychiatry 2004; 12: 7-21
• 4 O’Keeffe S, Lavan J. The prognostic significance of delirium in older hospital patients. J Am Geriatr Soc 1997; 45: 174-178
• 5 Neef D, Walling AD. Dementia with Lewy bodies: an emerging disease. Am Fam Physician 2006; 73: 1223-1229
• 6 Marcantonio ER, Rudolph JL, Culley D et al. Serum biomarkers for delirium. Gerontol A Biol Sci Med Sci 2006; 61: 1281-1286
• 7 Macdonald AJ. Can delirium be separated from dementia?. Dement Geriatr Cogn Disord 1999; 10: 86-88
• 8 Hshieh TT, Fong TG, Marcantonio ER et al. Cholinergic deficiency hypothesis in delirium: a synthesis of current evidence. J Gerontol A Biol Sci med Sci 2008; 63: 764-772
• 9 Inouye SK. Delirium in older persons. N Engl J Med 2006; 354: 1157-1165
• 10 Wolff HG, Curran D. Nature of delirium and allied states: the dysergastic reaction. Arch Neurol Psychiatr 1935; 33: 1175-1215
• 11 Bartus RT, Dean 3rd RL, Beer B et al. The cholinergic hypothesis of geriatric memory dysfunction. Science 1982; 217: 408-414
• 12 Steiner LA. Postoperative delirium. Part 1: pathophysiology and risk factors. Eur J Anaesthesiol 2011; 28: 628-636
• 13 Ross CA, Peyser CE, Shapiro I et al. Delirium: phenomenologic and etiologic subtypes. Int Psychogeriatrics 1991; 3: 135-147
• 14 Platt MM, Breitbart W, Smith M et al. Efficacy of neuroleptics for hypoactive delirium. J Neuropsychiatry Clin Neurosci 1994; 6: 66-67
• 15 O’Keeffe ST. Clinical subtypes of delirium in the elderly. Dement Geriatr Cogn Disord 1999; 10: 380-385
• 16 Yokota H, Ogawa S, Kurokawa A et al. Regional cerebral blood flow in delirium patients. Psychiatry Clin Neurosci 2003; 57: 337-339
• 17 Alsop DC, Fearing MA, Johnson K et al. The role of neuroimaging in elucidating delirium pathophysiology. J Gerontol A Biol Sci Med Sci 2006; 61: 1287-1293
• 18 Fong TG, Bogardus Jr ST, Daftary A et al. Cerebral perfusion changes in older delirious patients using 99mTc HMPAO SPECT. J Gerontol A Biol Sci Med Sci 2006; 61: 1294-1299
• 19 Soiza RL, Sharma V, Ferguson K et al. Neuroimaging studies of delirium: a systematic review. J Psychosom Res 2008; 65: 239-248
• 20 Loy CT, Schofield PR, Turner AM et al. Genetics of dementia. Lancet 2014; 383: 828-840
• 21 Ely EW, Girard TD, Shintani AK et al. Apolipoprotein E4 polymorphism as a genetic predisposition to delirium in critically ill patients. Crit Care Med 2007; 35: 112-117
• 22 Gross AL, Jones RN, Habtemariam DA et al. Delirium and Long-term Cognitive Trajectory Among Persons With Dementia. Arch Intern Med 2012; 172: 1324-1331
• 23 Jackson JC, Gordon SM, Hart RP et al. The association between delirium and cognitive decline: a review of the empirical literature. Neuropsychol Rev 2004; 14: 87-98
• 24 Kiely DK, Jones RN, Bergmann MA et al. Association between delirium resolution and functional recovery among newly admitted postacute facility patients. J Gerontol A Biol Sci Med Sci 2006; 61: 204-208
• 25 Rahkonen T, Luukkainen-Markkula R, Paanila S et al. Delirium episode as a sign of undetected dementia among community dwelling elderly subjects: A 2-year follow-up study. J Neurol Neurosurg Psychiatry 2000; 69: 519-521
• 26 Cole M, McCusker J, Dendukuri N et al. The prognostic significance of subsyndromal delirium in elderly medical inpatients. J Am Geriatr Soc 2003; 51: 754-760
• 27 Inouye SK, Rushing JT, Foreman MD et al. Does delirium contribute to poor hospital outcomes? A three-site epidemiologic study. J Gen Intern Med 1998; 13: 234-242
• 28 Rockwood K, Cosway S, Carver D et al. The risk of dementia and death after delirium. Age Ageing 1999; 28: 551-556
• 29 Rahn A. Delirium – management in the hospital: diagnosis and treatment. Z Gerontol Geriatr 2008; 41: 440-446
• 30 Lerner AJ, Hedera P, Koss E et al. Delirium in Alzheimer disease. Alzheimer Dis Assoc Disord 1997; 11: 16-20
• 31 Edlund A, Lundstrom M, Brannstrom B et al. Delirium before and after operation for femoral neck fracture. J Am Geriatr Soc 2001; 49: 1335-1340
• 32 Greene NH, Attix DK, Weldon BC et al. Measures of executive function and depression identify patients at risk for postoperative delirium. Anesthesiology 2009; 110: 788-795
• 33 Pisani MA, Redlich C, McNicoll L et al. Underrecognition of preexisting cognitive impairment by physicians in older ICU patients. Chest 2003; 124: 2267-2274
• 34 Fick D, Foreman M. Consequences of not recognizing delirium superimposed on dementia in hospitalized elderly individuals. J Gerontol Nurs 2000; 26: 30-40
• 35 Inouye SK. The dilemma of delirium: Clinical and research controversies regarding diagnosis and evaluation of delirium in hospitalized elderly medical patients. Am J Med 1994; 97: 278-288
• 36 Fick DM, Steis MR, Waller JL et al. Delirium superimposed on dementia is associated with prolonged length of stay and poor outcomes in hospitalized older adults. J Hosp Med 2013; 8: 500-505
• 37 Gustafson Y, Brannstrom B, Norberg G et al. Underdiagnosis and poor documentation of acute confusional states in elderly hip fracture patients. J Am Geriatr Soc 1991; 39: 760-765
• 38 Levkoff SE, Besdine R, Wetle T. Acute confusional states (delirium) in the hospitalized elderly. Annu Rev Gerontol Geriatr 1986; 6: 1-26
• 39 Rockwood K, Cosway S, Stolee P et al. Increasing the recognition of delirium in elderly patients. J Am Geriatr Soc 1994; 42: 252-256
• 40 Ryan DJ, O’Regan NA, Caoimh RÓ et al. Delirium in an adult acute hospital population: predictors, prevalence and detection. BMJ Open 2013; Jan 7; 3 (1); DOI: 10.1136/bmjopen-2012-001772
• 41 Han JH, Zimmerman EE, Cutler N et al. Delirium in older emergency department patients: recognition, risk factors, and psychomotor subtypes. Acad Emerg Med 2009; 16: 193-200
• 42 Fann JR. The epidemiology of delirium: a review of studies and methodological issues. Semin Clin Neuropsychiatry 2000; 5: 64-74
• 43 Lipowski ZJ. Delirium: acute confusional state. Oxford: Oxford university press; 1990
• 44 Slor CJ. Delirium motor subtypes in elderly hip fracture patients: Risk factors, outcomes and longitudinal stability. J Psychosom Res 2013; 74: 444-449
• 45 Farrell KR, Ganzini L. Misdiagnosing delirium as depression in medically ill elderly patients. Archives of Internal Medicine 1995; 155: 2459-2464
• 46 Stanga Z, Immer FF, Allemann P et al. Akute Verwirrtheitszustände. Schweiz Med Forum 2002; 43: 1021-1028
• 47 Agostini JV, Leo-Summer LS, Inouye SK. Cognitive and other adverse effects of diphenhydramine use in hospitalized older patients. Arch Intern Med 2001; 161: 2091-2097
• 48 Chan M, Nicklason F, Vial JH. Adverse drug events as a cause of hospital admission in the elderly. Intern Med J 2001; 31: 199-205
• 49 Inouye SK, Westendorp RGJ, Saczynski JS. Delirium in elderly people. Lancet 2014; 383: 911-922
• 50 Francis J, Kapoor WN. Delirium in hospitalized elderly. J Gen Intern Med 1990; 5: 65-79
• 51 Deiner S, Silverstein JH. Postoperative delirium and cognitive dysfunction. Br J Anaesth 2009; 103 (Suppl. 01) 41-46
• 52 Arend E, Christensen M. Delirium in the intensive care unit: a review. Nurs Crit Care 2009; 14: 145-154
• 53 Cole MG, Primeau FJ, Élie LM. Delirium: prevention, treatment, and outcome studies. J Geriatr Psychiatry Neurol 1998; 11: 126-137
• 54 Cole MG, Primeau FJ, McCusker J. Effectiveness of interventions to prevent delirium in hospitalized patients: a systematic review. CMAJ 1996; 155: 1264-1268
• 55 Gesin G, Russell BB, Lin AP et al. Impact of a delirium screening tool and multifaceted education on nurses' knowledge of delirium and ability to evaluate it correctly. J Crit Care 2012; 21: 1-11
• 56 Van de Steeg L, Langelaan M, Ijkema R et al. The effect of a complementary e-learning course on implementation of a quality improvement project regarding care for elderly patients: a stepped wedge trial. Sci 2012; 7: 13
• 57 McCrow J, Sullivan KA, Beattie ER. Delirium knowledge and recognition: A randomized controlled trial of a web-based educational intervention for acute care nurses. Nurse Educ Today 2014; 34: 912-917
• 58 Breitbart W, Marotta R, Platt MM et al. A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients. Am J Psychiatry 1996; 153: 231-237
• 59 Hu H, Deng W, Yang H et al. Olanzapine and haloperidol for senile delirium: a randomized controlled observation. Chin J Clin Rehab 2006; 10: 188-190
• 60 Han CS, Kim YK. A double-blind trial of risperidone and haloperidol for the treatment of delirium. Psychosomatics 2004; 45: 297-301
• 61 Liu CY, Juang YY, Liang HY et al. Efficacy of risperidone in treating the hyperactive symptoms of delirium. Int Clin Psychopharmacol 2004; 19: 165-168
• 62 Mittal D, Jimerson NA, Neely EP et al. Risperidone in the treatment of delirium: results from a prospective open-label trial. J Clin Psychiatry 2004; 65: 662-667
• 63 Parellada E, Baeza I, Pablo JD et al. Risperidone in the treatment of patients with delirium. J Clin Psychiatry 2004; 65: 348-353
• 64 Kim KS, Pae CU, Chae JH et al. An open pilot trial of olanzapine for delirium in the Korean population. Psychiatry Clin Neurosci 2001; 55: 515-519
• 65 Sipahimalani A, Masand PS. Olanzapine in the treatment of delirium. Psychosomatics 1998; 39: 422-430
• 66 Skrobik YK, Bergeron N, Dumont M et al. Olanzapine vs haloperidol: treating delirium in a critical care setting. Intensive Care Med 2004; 30: 444-449
• 67 Seitz DP, Gill SS, van Zyl LT. Antipsychotics in the treatment of delirium: a systematic review. J Clin Psychiatry 2007; 68: 11-21
• 68 Lonergan E, Britton AM, Luxenberg J et al. Antipsychotics for delirium. Cochrane Database Syst Rev 2007; 2 CD005594
• 69 Wang PS, Schneeweiss S, Avorn J et al. Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med 2005; 353: 2335-2341
• 70 Kim KY, Bader GM, Kotlyar V et al. Treatment of delirium in older adults with quetiapine. J Geriatr Psychiatry Neurol 2003; 16: 29-31
• 71 Sasaki Y, Matsuyama T, Inoue S et al. A prospective, open-label, flexible-dose study of quetiapine in the treatment of delirium. J Clin Psychiatry 2003; 64: 1316-1321
• 72 Schwartz TL, Masand PS. Treatment of delirium with quetiapine. Prim Care Companion J Clin Psychiatry 2000; 2: 10-12
• 73 Tahir T, Eeles E, Reddy V et al. A randomized control trial of quetiapine versus placebo in the treatment of delirium. XI Scientific Meeting of EACLPP and XXVII ECPR, Vol 64: 677
• 74 Lee KU, Won WY, Lee HK et al. Amisulpride versus quetiapine for the treatment of delirium: a randomized, open prospective study. Int Clin Psychopharmacol 2005; 20: 311-314
• 75 Alao AO, Soderberg M, Pohl EL et al. Aripiprazole in the treatment of delirium. Int J Psychiatry Med 2005; 35: 429-433
• 76 Alao AO, Moskowitz L. Aripiprazole and delirium. Ann Clin Psychiatry 2006; 18: 267-269
• 77 Straker DA, Shapiro PA, Muskin PR. Aripiprazole in the treatment of delirium. Psychosomatics 2006; 47: 385-391
• 78 Pandharipande P, Shintani A, Peterson J et al. Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients. Anesthesiology 2006; 104: 21-26
• 79 Marcantonio ER, Goldman L, Mangione CM et al. A clinical prediction rule for delirium after elective noncardiac surgery. JAMA 1994; 271: 134-139
• 80 Leipzig RM, Cumming RG, Tinetti ME. Drugs and falls in older people: a systematic review and meta-analysis: I. Psychotropic Drugs. J Am Geriatr Soc 1999; 47: 30-39
• 81 Swift CG. Pharmacodynamics: changes in homeostatic mechanisms, receptor and target organ sensitivity in the elderly. Br Med Bull 1990; 46 (01) 36-52
• 82 Fernandez F, Levy JK, Mansell PWA. Management of delirium in terminally ill AIDS patients. Int J Psychiatry Med 1989; 19: 165-172
• 83 Adams F, Fernandez F, Andersson BS. Emergency pharmacotherapy of delirium in the critically ill cancer patient. Psychosomatics 1986; 27 (Suppl. 01) 33-38
• 84 Menza MA, Murray GB, Holmes VF. Controlled study of extrapyramidal reactions in the management of delirious medically ill patients: intravenous haloperidol versus intravenous haloperidol plus benzodiazepines. Heart Lung 1988; 17: 238-241
• 85 Trzepacz PT. Anticholinergic model for delirium. Semin Clin Neuropsychiatry 1996; 1: 294-303
• 86 Flacker JM, Cummings V, Mach JR et al. The association of serum anticholinergic activity with delirium in elderly medical patients. Am J Geriatr Psychiatry 1998; 6: 31-41
• 87 Marcantonio ER, Palihnich K, Appleton P et al. Pilot randomized trial of donepezil hydrochloride for delirium after hip fracture. Am Geriatr Soc 2011; 59 (Suppl. 02) 282-288
• 88 Liptzin B, Laki A, Garb JL et al. Donepezil in the prevention and treatment of post-surgical delirium. Am J Geriatr Psychiatry 2005; 13: 1100-1106
• 89 Sampson EL, Raven PR, Ndhlovu PN et al. A randomized, double-blind, placebo-controlled trial of donepezil hydrochloride (Aricept) for reducing the incidence of postoperative delirium after elective total hip replacement. J Geriatr Psychiatry 2007; 22: 343-349
• 90 Kobayashi K, Higashima M, Mutou K et al. Severe delirium due to basal forebrain vascular lesion and efficacy of donepezil. Prog Neuropsychopharma Biol Psychiatry 2004; 28: 1189-1194
• 91 Van Eijk MM, Roes KC, Honing ML et al. Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial. Lancet 2010; 376 (9755) 1829-1837
• 92 Tabet N, Hudson S, Sweeney V et al. An educational intervention can prevent delirium on acute medical wards. Age & Ageing 2005; 34: 152-156
• 93 Kratz T. Delir bei Demenz. Z Gerontol Geriat 2007; 40: 96-103
• 94 Grover S, Kate N. Assessment scales for delirium: A review. Aging & Mental Health 2010; 14: 543-555
• 95 Adamisa D, Sharmab N, Whelanc PJ et al. Delirium scales: A review of current evidence. Mental Health 2010; 14: 543-555
• 96 Inouye SK, Bogardus ST, Charpentier PA et al. Yale Delirium Trial, A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med 1999; 340: 669-676
• 97 Inouye SK, Bogardus Jr ST, Baker DI et al. The Hospital Elder Life Program: a model of care to prevent cognitive and functional decline in older hospitalized patients. J Am Geriatr Soc 2000; 48: 1697-1706
• 98 Zaubler TS, Murphy K, Rizzuto L. Quality Improvement and Cost Savings with Multicomponent Delirium Interventions: Replication of the Hospital Elder Life Program in a Community Hospital. Psychosomatics 2013; 54: 219-226
• 99 Marcantonio ER, Flacker JM, Wright RJ et al. Reducing Delirium After Hip Fracture: A Randomized Trial. J Am Geriatr Soc 2001; 49 (05) 516-522
• 100 Kalisvaart KJ, de Jonghe JFM, Bogaards MJ et al. Haloperidol prophylaxis for elderly hip fracture patients at risk for delirium: a randomized, placebo-controlled study. J Am Geriatr Soc 2005; 53: 1658-1666
• 101 McKeith I, Fairbairn A, Perry R et al. Neuroleptic sensitivity in patients with senile dementia of Lewy body type. BMJ 1992; 305 (6855) 673-678
• 102 Sadek J, Rockwood K. Coma with accidental single dose of an atypical neuroleptic in a patient with Lewy body dementia. Am J Geriatr Psychiatry 2003; 11: 112-113
• 103 Aarsland D, Perry R, Larsen JP et al. Neuroleptic sensitivity in Parkinson’s disease and parkinsonian dementias. J Clin Psychiatry 2005; 66: 633-637
• 104 Ballard C, Grace J, McKeith I et al. Neuroleptic sensitivity in dementia with Lewy bodies and Alzheimer’s disease. Lancet 1998; 351 (9108) 1032-1033
• 105 Friedman JH. Parkinson’s disease psychosis 2010: a review article. Parkinsonism Relat Disord 2010; 16: 553-560
• 106 Fernandez HH, Trieschmann ME, Burke MA et al. Quetiapine for psychosis in Parkinson’s disease versus dementia with Lewy bodies. J Clin Psychiatry 2002; 63: 513-515
• 107 Onor ML, Saina M, Aguglia E. Efficacy and tolerability of quetiapine in the treatment of behavioral and psychological symptoms of dementia. Am J Alzheimer’s Dis Other Dementias 2006; 21: 448-453
• 108 Takahashi H, Yoshida K, Sugita T et al. Quetiapine treatment of psychotic symptoms and aggressive behavior in patients with dementia with Lewy bodies: a case series. Progress Neuro-Psychopharmacol Biol Psychiatry 2003; 27: 549-553
• 109 Eggert KM, Oertel WH, Reichmann H. Parkinson Syndrome – Diagnostik und Therapie. Leitlinien für Diagnostik und Therapie in der Neurologie, Deutsche Gesellschaft für Neurologie 2012
• 110 The French Clozapine Parkinson Study Group. Clozapine in drug-induced psychosis in Parkinson’s disease. Lancet 1999; 353 (9169) 2041-2042
• 111 The Parkinson Study Group. Low-dose clozapine for the treatment of drug-induced psychosis in Parkinson’s disease. N Engl J Med 1999; 340 (10) 757-763
• 112 Martin J, Heymann A, Bäsell K et al. AWMF online – S3-Leitlinie: Analgesie, Sedierung und Delirmanagement in der Intensivmedizin. Ger Med Sci 2010; Doc02. 8